CN101522662A - 喹诺酮羧酸、其衍生物、及其制备方法和其用作抗菌剂的用途 - Google Patents

喹诺酮羧酸、其衍生物、及其制备方法和其用作抗菌剂的用途 Download PDF

Info

Publication number
CN101522662A
CN101522662A CNA2007800375227A CN200780037522A CN101522662A CN 101522662 A CN101522662 A CN 101522662A CN A2007800375227 A CNA2007800375227 A CN A2007800375227A CN 200780037522 A CN200780037522 A CN 200780037522A CN 101522662 A CN101522662 A CN 101522662A
Authority
CN
China
Prior art keywords
substituted
formula
unsubstituted
fluoroquinolone
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800375227A
Other languages
English (en)
Chinese (zh)
Inventor
A·E.·哈姆斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Publication of CN101522662A publication Critical patent/CN101522662A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA2007800375227A 2006-10-06 2007-09-24 喹诺酮羧酸、其衍生物、及其制备方法和其用作抗菌剂的用途 Pending CN101522662A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84992406P 2006-10-06 2006-10-06
US60/849,924 2006-10-06

Publications (1)

Publication Number Publication Date
CN101522662A true CN101522662A (zh) 2009-09-02

Family

ID=39186175

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800375227A Pending CN101522662A (zh) 2006-10-06 2007-09-24 喹诺酮羧酸、其衍生物、及其制备方法和其用作抗菌剂的用途

Country Status (12)

Country Link
US (1) US8227597B2 (enExample)
EP (1) EP2074111A2 (enExample)
JP (1) JP2010505861A (enExample)
KR (1) KR20090061029A (enExample)
CN (1) CN101522662A (enExample)
AU (1) AU2007307995B2 (enExample)
BR (1) BRPI0717513A2 (enExample)
CA (1) CA2663044C (enExample)
MX (1) MX2009003313A (enExample)
SG (1) SG172744A1 (enExample)
TW (1) TWI383978B (enExample)
WO (1) WO2008045673A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101759629B (zh) * 2009-12-22 2012-01-11 北大方正集团有限公司 西他沙星中间体的制备方法
CN102659761A (zh) * 2012-04-27 2012-09-12 常州市亚邦医药研究所有限公司 盐酸贝西沙星的制备方法
CN104327107A (zh) * 2013-10-17 2015-02-04 广东东阳光药业有限公司 一种氟喹诺酮类抗菌药物的制备方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252783B2 (en) * 2007-01-24 2012-08-28 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US20080200442A1 (en) * 2007-02-16 2008-08-21 Srini Venkatesh Compositions and Methods for Treating, Reducing, Ameliorating, or Preventing Infections of the Ear or Upper Respiratory Tract
US8415342B2 (en) 2008-10-29 2013-04-09 Bausch & Lomb Incorporated Besifloxacin ophthalmic composition for the treatment or control of infection
BR122020021551B1 (pt) 2008-11-15 2021-09-21 Melinta Subsidiary Corp Composição farmacêutica antimicrobiana e seu uso
US8481526B2 (en) * 2009-03-25 2013-07-09 Bausch & Lomb Incorporated Fluoroquinolone carboxylic acid molecular crystals
CN101974578B (zh) * 2010-10-21 2014-06-11 杭州师范大学 一种复合酶催化水解制备喹诺酮类羧酸中间体的方法
US10167271B2 (en) 2015-01-28 2019-01-01 Mankind Pharma Ltd Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines
JPS606684A (ja) * 1983-06-24 1985-01-14 Hokuriku Seiyaku Co Ltd ７−ホモピペラジン置換−６，８−ジフルオロ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
EP0230946A3 (en) 1986-01-20 1988-09-07 Kyorin Pharmaceutical Co., Ltd. Process for the preparation of quinolonecarboxylic acid derivatives
JPS63132885A (ja) * 1986-11-25 1988-06-04 Hokuriku Seiyaku Co Ltd キノリン−３−カルボン酸誘導体
JPS63196580A (ja) * 1987-02-09 1988-08-15 Hokuriku Seiyaku Co Ltd キノリン−３−カルボン酸誘導体
JPS63196579A (ja) * 1987-02-09 1988-08-15 Hokuriku Seiyaku Co Ltd キノリン−３−カルボン酸誘導体
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
TW222272B (enExample) * 1992-05-26 1994-04-11 Ss Seiyaku Kk
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
TW301607B (enExample) * 1993-03-09 1997-04-01 Takeda Pharm Industry Co Ltd
FR2706459B1 (fr) * 1993-06-17 1995-08-04 Bouchara Sa Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
EP0931078B1 (en) * 1996-09-13 2006-11-15 Schering Corporation Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
JP4612301B2 (ja) * 2003-12-26 2011-01-12 広栄化学工業株式会社 １−アルキル−４−アミノメチルピペリジンの製造法
DE102004035203A1 (de) * 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101759629B (zh) * 2009-12-22 2012-01-11 北大方正集团有限公司 西他沙星中间体的制备方法
CN102659761A (zh) * 2012-04-27 2012-09-12 常州市亚邦医药研究所有限公司 盐酸贝西沙星的制备方法
CN102659761B (zh) * 2012-04-27 2017-10-10 常州市亚邦医药研究所有限公司 盐酸贝西沙星的制备方法
CN104327107A (zh) * 2013-10-17 2015-02-04 广东东阳光药业有限公司 一种氟喹诺酮类抗菌药物的制备方法

Also Published As

Publication number Publication date
SG172744A1 (en) 2011-07-28
TWI383978B (zh) 2013-02-01
US20120157447A1 (en) 2012-06-21
AU2007307995B2 (en) 2013-01-17
WO2008045673A3 (en) 2008-05-29
AU2007307995A1 (en) 2008-04-17
KR20090061029A (ko) 2009-06-15
TW200827348A (en) 2008-07-01
BRPI0717513A2 (pt) 2013-11-19
MX2009003313A (es) 2009-04-09
JP2010505861A (ja) 2010-02-25
CA2663044A1 (en) 2008-04-17
WO2008045673A2 (en) 2008-04-17
CA2663044C (en) 2012-07-24
US8227597B2 (en) 2012-07-24
EP2074111A2 (en) 2009-07-01

Similar Documents

Publication Publication Date Title
AU2007307995B2 (en) Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents
CA2674543C (en) Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US7868021B2 (en) Antimicrobial quinolones, their compositions and uses
US7019143B2 (en) Antimicrobial quinolones, their compositions and uses
JPH0145468B2 (enExample)
JPS62129273A (ja) １−シクロプロピル−６−フルオロ−１，４−ジヒドロ−４−オキソ−７−（１−ピペラジニル）−３−キノリンカルボン酸類
EP0178388A1 (en) Quinolinecarboxylic acid derivatives
US8252783B2 (en) Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
JPH02290870A (ja) 対掌体的に純粋な７‐（３‐アミノ‐１‐ピロリジニル）‐キノロン‐および‐ナフチリドンカルボン酸
JPH06199835A (ja) ８−ジフルオロメトキシキノリン−３−カルボン酸誘導体
JPH0637489B2 (ja) キノロンカルボン酸誘導体およびその製造方法
WO2019096234A1 (zh) 一组具有抗耐药性细菌活性的化合物、其制备方法和应用
JPH06145167A (ja) ８−メトキシ−５−メチルキノリン−３−カルボン酸誘導体
JPH0366688A (ja) １，４―ジヒドロ―４―オキソナフチリジン化合物
JPH05112554A (ja) 新規なキノロンカルボン酸誘導体
JPH0413355B2 (enExample)
JPWO2002018344A1 (ja) 新規なエステル又はアミド誘導体
JPS6233188A (ja) ベンゾヘテロ環化合物
WO2005030752A1 (ja) ８−シアノキノロンカルボン酸誘導体
JPH02160766A (ja) キノロン誘導体及びその塩、これらの製法並びに感染症治療剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090902